United States federal and state rules and regulations during public health emergencies: navigating novel coronavirus
NIH Finalizes New Drug and Device Clinical Trial Reporting Requirements
Navigating the Regulatory Issues of 3D Printing
CMS Seeks Public Comment on its Imposition of CMPs for Noncompliance with Medicare Secondary Payer Reporting Requirements; Opportunity for Clinical Trial Sponsors to Request Discretion
FDA Draft Guidance on Safety Data Collection for Late Stage Premarket & Postmarket Investigations
CMS and FDA Announce Parallel Review Pilot Program
Prospects Unclear for CMS/FDA Proposed Parallel Review of Medical Products
Subscribe: Subscribe via RSS